130 related articles for article (PubMed ID: 31439373)
1. NMR characterization of the interaction between Bcl-x
Kusunoki H; Tanaka T; Kohno T; Kimura H; Hosoda K; Wakamatsu K; Hamaguchi I
Biochem Biophys Res Commun; 2019 Oct; 518(3):445-450. PubMed ID: 31439373
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction.
Zhang TY; Chen HY; Cao JL; Xiong HL; Mo XB; Li TL; Kang XZ; Zhao JH; Yin B; Zhao X; Huang CH; Yuan Q; Xue D; Xia NS; Yuan YA
Nat Commun; 2019 Jul; 10(1):3192. PubMed ID: 31324803
[TBL] [Abstract][Full Text] [Related]
3. Chemical shift assignments of a fusion protein comprising the C-terminal-deleted hepatitis B virus X protein BH3-like motif peptide and Bcl-x
Kusunoki H; Hamaguchi I; Kobayashi N; Nagata T
Biomol NMR Assign; 2022 Oct; 16(2):357-361. PubMed ID: 36044106
[TBL] [Abstract][Full Text] [Related]
4. Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx.
Jiang T; Liu M; Wu J; Shi Y
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2074-9. PubMed ID: 26858413
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification and characterization of hepatitis B virus X protein BH3-like motif-linker-Bcl-x
Kusunoki H; Tanaka T; Kohno T; Kimura H; Hosoda K; Wakamatsu K; Hamaguchi I
Biochem Biophys Rep; 2017 Mar; 9():159-165. PubMed ID: 29114584
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of the BH3-like motif of hepatitis B virus X protein.
Kusunoki H; Tanaka T; Kohno T; Wakamatsu K; Hamaguchi I
Biochem Biophys Res Commun; 2014 Jul; 450(1):741-5. PubMed ID: 24950407
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Interaction between the C-Terminal-Deleted BH3-like Motif Peptide of Hepatitis B Virus X Protein and Bcl-x
Kusunoki H; Sakamoto T; Kobayashi N; Kohno T; Wakamatsu K; Nagata T
Biochemistry; 2024 Mar; 63(5):632-643. PubMed ID: 38377677
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction.
Geng X; Huang C; Qin Y; McCombs JE; Yuan Q; Harry BL; Palmer AE; Xia NS; Xue D
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18471-6. PubMed ID: 23091012
[TBL] [Abstract][Full Text] [Related]
9. Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft.
Zhang YH; Bhunia A; Wan KF; Lee MC; Chan SL; Yu VC; Mok YK
J Mol Biol; 2006 Dec; 364(3):536-49. PubMed ID: 17011577
[TBL] [Abstract][Full Text] [Related]
10. Behavior of solvent-exposed hydrophobic groove in the anti-apoptotic Bcl-XL protein: clues for its ability to bind diverse BH3 ligands from MD simulations.
Lama D; Modi V; Sankararamakrishnan R
PLoS One; 2013; 8(2):e54397. PubMed ID: 23468841
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the interaction between DJ-1 and Bcl-X
Lee MK; Lee MS; Bae DW; Lee DH; Cha SS; Chi SW
Biochem Biophys Res Commun; 2018 Jan; 495(1):1067-1073. PubMed ID: 29175327
[TBL] [Abstract][Full Text] [Related]
12. Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-X
Reddy CN; Manzar N; Ateeq B; Sankararamakrishnan R
Biochemistry; 2020 Nov; 59(45):4379-4394. PubMed ID: 33146015
[TBL] [Abstract][Full Text] [Related]
13. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
Rajan S; Choi M; Baek K; Yoon HS
Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1.
Feng W; Huang S; Wu H; Zhang M
J Mol Biol; 2007 Sep; 372(1):223-35. PubMed ID: 17659302
[TBL] [Abstract][Full Text] [Related]
15. TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL.
Thébault S; Agez M; Chi X; Stojko J; Cura V; Telerman SB; Maillet L; Gautier F; Billas-Massobrio I; Birck C; Troffer-Charlier N; Karafin T; Honoré J; Senff-Ribeiro A; Montessuit S; Johnson CM; Juin P; Cianférani S; Martinou JC; Andrews DW; Amson R; Telerman A; Cavarelli J
Sci Rep; 2016 Jan; 6():19725. PubMed ID: 26813996
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into mouse anti-apoptotic Bcl-xl reveal affinity for Beclin 1 and gossypol.
Priyadarshi A; Roy A; Kim KS; Kim EE; Hwang KY
Biochem Biophys Res Commun; 2010 Apr; 394(3):515-21. PubMed ID: 20206602
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus X Protein Function Requires Zinc Binding.
Ramakrishnan D; Xing W; Beran RK; Chemuru S; Rohrs H; Niedziela-Majka A; Marchand B; Mehra U; Zábranský A; Doležal M; Hubálek M; Pichová I; Gross ML; Kwon HJ; Fletcher SP
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167910
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
